NEWS

OUR PROPRIETARY TECHNOLOGY
OUR PROPRIETARY TECHNOLOGY

MyCells is our proprietary, first of its kind technology that uses dental pulp and wharton`s jelly stem cells to treat debilitating diseases. 

Our products
Our products

Hygieia Innovation is an innovation driven clinical stage biopharmaceutical company focused on developing novel stem cell therapeutics to address major unmet medical needs. 
 

Biosurgery
Biosurgery

Synthetic bone graft with stem cells for faster bone healing. 

Hygieia Innovation Scientists have developed a combination of bone graft and stem cells that may replace the traditional bone grafting.